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New information indicates that toxoca-
riasis is the most common human parasitic
worm infection in the United States,
affecting millions of Americans living in
poverty. The infection is also highly
prevalent in many developing countries
and its global importance may be greatly
underestimated.
Toxocariasis results from zoonotic trans-
mission of the roundworms, Toxocara canis
and T. cati from dogs and cats, respectively.
Infection occurs when humans accidentally
ingest the microscopic, oval and thick-
shelled-embryonated eggs (shed in dog and
cat feces) containing Toxocara larvae by
hand-to-mouth contact. Children are par-
ticularly prone to infection because they are
exposed to the eggs on sandboxes and
playgroundscontaminated with dog and cat
feces [1,2]. After ingestion of the eggs, the
released larvae penetrate the intestine and
migrate through the liver,lungs, and central
nervous system (Figure 1). The resulting
hostinflammatoryresponse ultimately over-
whelms and either kills the migrating larvae
or forces them into a state of arrested
development, but not before they cause
both mechanical and immunopathological
damage to the issues (Figure 2).
There are two ‘‘classical’’ clinical syn-
dromes resulting from infection [1,2].
Visceral larva migrans occurs most com-
monly in young children and results in
hepatitis and pneumonitis as the larvae
migrate through the liver and lungs,
respectively. The full clinical presentation
of toxocariasis includes hepatomegaly and
pulmonary infiltrates or nodules accom-
panied by cough, wheezing, eosinophilia,
lymphadenopathy, and fever. Larval entry
into the central nervous system can also
result in meningoencephalitis and cerebri-
tis manifesting as seizures [3,4]. Ocular
larva migrans occurs more frequently in
older children and adolescents and may
result from the migration of even a single
larva in the eye. The resulting inflamma-
tion presents clinically as either a granu-
loma or a granulomatous larval track in
the retina or as a condition of the vitreous
that resembles endophthalmitis [5,6]. Nei-
ther visceral larva migrans nor ocular
larva migrans are considered common
conditions, although the incidence of the
former has not been determined and it has
been estimated at just under 1 per 10,000
annually for the ocular form [6]. Far more
common is non-classic, or covert toxoca-
riasis, which may manifest with only some
of the clinical features found in visceral
larva migrans, especially wheezing, pul-
monary infiltrates, and eosinophilia [2].
Because these features are also the hall-
mark of childhood asthma, some investi-
gators have hypothesized or in some cases
have actually shown a link with Toxocara
infection [2,7–14]. Similarly, some of the
central nervous system features of toxoca-
riasis have been implicated as a cause of
occult seizures, mental retardation, and
developmental delays [3,4,15]. Because
pica is a risk factor for both toxocariasis
and lead ingestion [16], it is possible that
an element of the cognitive and mental
deficits ascribed to toxocariasis may par-
tially result from plumbism.
There are an estimated 73 million dogs
and 90 million cats in the United States
[17]. Many pups are born with congenital
canine toxocariasis and large numbers of
both dogs and cats are either stray animals
or pets that are not routinely dewormed as
recommended by the American Veteri-
nary Medical Association [18]. Such huge
numbers of Toxocara-infected dogs and cats
serve as rich sources of eggs in the
environment, which have been recovered
in poor urban areas [16] as well as in rural
areas, especially in the American South
and Appalachia [19–21]. Most of the
prevalence estimates for toxocariasis in
the US are based on serological surveys
with banked sera that detect Toxocara-
specific antibodies [17,20,22]. The en-
zyme immunoassay (EIA) using T. canis
excretory-secretory (TES) antigens from
infective-stage larvae is the most useful
diagnostic test for toxocaral visceral larva
migrans and ocular larva migrans and is
the assay used by most commercial
reference laboratories in the US, including
the reference laboratory at the US Centers
for Disease Control and Prevention (CDC)
[17,20,22–31]. Results from the CDC EIA
measure total immunoglobulin antibodies
and are reported as a titer; the assay detects
infectionscausedbybothT.canis and T.cati.
For visceral larva migrans and some forms
of covert toxocariasis, the sensitivity and
specificity of the ToxocaraEIA isestimatedat
78%and 92%,respectively,ata titerof1:32
[17,22,26,27]. The sensitivity of the EIA for
ocular larva migrans, however, is consider-
ably less [1,28]. Following initial infection,
Toxocara larvae migrate through host tissues
for several months, and ultimately generate
a host granulomatous response, which
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the larvae may remain alive within the host
for months, and host antibody levels may
remain strongly positive for 2 or 3 years or
more [17,31]. Therefore, in the CDC EIA,
the presence of antibody titers greater than
1:32 may be considered reflective of active
infection, although we are not aware of
careful studies that have determined the
length of persistent toxocaral antibodies
over long periods of time.
Using a nationally representative set of
banked sera, the CDC has undertaken two
major national surveys for toxocariasis
[17,20,22]. The first was reported more
than 20 years ago using sera from children
aged 1 to 11 that were collected during the
first Health and Nutrition Examination
Survey (HANES I) of over 23,000 persons
1 to 74 years of age in 35 geographic
regions from 1971 to 1973 [20]. Nation-
wide, the overall prevalence was found to
vary between 4.6% and 7.3%, but ranged
as high as 10% in the American South and
over 30% for socioeconomically disadvan-
taged African American children [20].
Higher seroprevalence was also linked to
markers of low socioeconomic status,
including poverty and crowding and lower
educational level for head of household
[20]. In 2008, the CDC again reported on
Toxocara seroprevalence from the Third
National Health and Nutrition Examina-
tion Survey (NHANES III), a cross-
sectional survey conducted between 1988
and 1994 [17,22]. The survey sampled at
higher rates specific minority groups (e.g.,
non-Hispanic blacks and Mexican Amer-
icans) and age groups (young children and
the elderly) [17]. Based on a representative
sample of just over 20,000 in individuals
over the age of 6, the overall seropreva-
lence was 13.9% [17,22], suggesting that
tens of millions of Americans are infected
with Toxocara. However, the seropreva-
Figure 1. The Life Cycle of Human Infection with Toxocara canis. From the Public Health Image Library of the CDC, http://phil.cdc.gov.
doi:10.1371/journal.pntd.0000400.g001
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among non-Hispanic blacks and people
living in poverty. Based on the number of
African Americans living in poverty in the
US, we calculated that as many as 2.8
million have toxocariasis, making this
disease one of the most common infections
among any underrepresented minority
groups [32]. In a separate study conducted
in the 1990s, high rates of toxocariasis
were also found among inner city Hispanic
populations in Bridgeport and New Ha-
ven, Connecticut, especially among Puerto
Rican immigrants [14]. High rates of the
infection were noted previously to occur in
Puerto Rico [33]. Given its proposed links
with asthma and developmental delays,
human toxocariasis may represent a health
disparity of staggering proportions, possi-
bly associated with the high frequency of
asthma and developmental delays noted
among African Americans and some
Hispanic groups living in poverty [34–
37]. The earlier association noted between
toxocariasis and elevated lead levels ob-
served in the HANES I study was
confirmed in the NHANES III serum
bank data, as was an interesting associa-
tion between toxocariasis and co-infection
with toxoplasmosis [17,22]. The health
and developmental impact of these co-
factors also warrants further investigation.
Globally, high rates of toxocariasis has
been noted in middle-income countries,
with prevalence rates reaching 40% or
higher in Indonesia and Brazil [30,38].
Although there are few reported studies
from low-income countries, it is of great
interest to determine whether infection
rates with Toxocara may exceed some of the
better known human soil-transmitted hel-
minth infections such as ascariasis, trich-
uriasis, or hookworm infection.
While the NHANES studies indicate
that toxocariasis continues to persist and is
under-recognized as a health problem, a
full appreciation of the US and global
burden of disease caused by toxocariasis
demands improved serodiagnostic tools. In
the US, EIA testing is not widely available
because of the limited capacity for para-
sitic disease diagnosis in the US and the
limited availability of antigen made from
T. canis larvae. In addition, the existing
assays have a low sensitivity for detecting
ocular larva migrans, so some true cases
remain undiagnosed and the approxima-
tions of national seroprevalence are un-
derestimated. These features, together
with the observation that many physicians
in the US are not knowledgeable about the
infection, helps to preserve the neglected
status of toxocariasis. In developing coun-
tries, survey results based on EIA with
TES are confounded by high rates of co-
infections with other soil-transmitted hel-
minths, as antibodies to these other
nematodes may cross-react to T.canis
antigens [29,38]. In an effort to increase
both the sensitivity and specificity of TES-
based EIAs, some investigators have
examined the advantages of measuring
IgG subclass antibodies. At least one study
has shown that sensitivity could be in-
creased by measuring IgG2 subclass anti-
bodies, presumably those that measure
anti-carbohydrate antibodies against TES
glycans, while specificity could be in-
creased by measuring IgG3 or IgG4
antibodies [29,30]. In 2000, a 30-kDa
recombinant TES antigen was cloned and
expressed in bacteria [39]. The recombi-
nant protein requires solubilization in urea
(which may lessen its usability in an EIA
format), but is undergoing evaluation as a
potentially improved diagnostic reagent
[38], as are other recombinant T. canis
antigens [40]. Ultimately, further epide-
miological studies and disease burden
assessments of toxocariasis would benefit
from the development of an immunodiag-
nostic assay that is both highly sensitive
and specific for (and uses) the detection of
antibodies to a chemically defined recom-
binant T. canis antigen, preferably one that
is soluble in aqueous solution, and would
be made widely available. Production of
recombinant antigens may require expres-
sion in yeast or other low-cost eukaryotic
expression vectors, which are often pref-
erable to bacteria for producing soluble
recombinant nematode antigens [41,42].
Alternatively, tests could be developed for
measuring the presence of Toxocara antigen
in the bloodstream, similar to the immu-
nochromatographic test (ICT) developed
for lymphatic filariasis [43] or tests for
other helminth infections [44].
Further studies to improve diagnostic
testing and expand epidemiologic surveil-
lance should be conducted in parallel with
control and prevention efforts. These
include periodic deworming of dogs (espe-
cially after whelping) and hand-washing to
prevent fecal oral contact [18], and case-
detection and treatment with albendazole
[45]. Given the high prevalence of toxo-
cariasis in areas of poor urban and rural
hygiene [16,21], improved sanitation and
access to clean water may also have
important roles. As a potential explanation
for the high rates of asthma and develop-
mental delays among disadvantaged chil-
dren in poor urban and rural areas, there
is an urgent need to fully explore the
contribution of toxocariasis to these con-
ditions, which in turn will require in-
creased advocacy and resource mobiliza-
tion. Recognition of toxocariasis as a
common parasitic disease in the US and
possibly an even greater health problem in
developing countries is a first important
step to national and international efforts to
combat this neglected infection of poverty.
Figure 2. Toxocara Larva in Liver of Child Necropsied in New Zealand. Larva discovered
at some distance from lesion. Image courtesy of CDC and DPDx.
doi:10.1371/journal.pntd.0000400.g002
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